TIDES Europeで、イノベーションのインパクトを倍増
TIDES Europeのお申し込み時に、追加オプションとして「Post-Event Meeting」を選択すると、「イベント後のシンポジウム：OSI Europe」（11月6日開催）に参加できます。
詳細については、株式会社グローバルインフォメーションまでお問い合わせ下さい。
最高の2会議、強烈なエクスペリエンス
OSI Europe 2026のアジェンダのスナップショット
GLP-1から多重アゴニストへ、次世代療法
Exploring clinical updates from leading GLP-1, dual, and triple agonist programs across peptide and small molecule modalities, including efficacy data and novel oral formulations addressing limitations of injectable therapies.
RNAベースのアプローチ
Exploring RNA-based approaches for obesity, including siRNA-mediated inhibition of metabolic targets and non-coding RNA technologies with insights from Phase 1 clinical data.
欧州の市場参入と商業化戦略
Navigating regulatory pathways, reimbursement frameworks, and market access challenges to successfully translate innovative obesity therapeutics into commercially viable solutions across diverse European healthcare systems.
投資・評価・戦略的パートナーシップ
Examining valuation trends, licensing opportunities, and strategic collaborations shaping the obesity therapeutics landscape, with insights from leading investors, pharma BD&L teams, and emerging biotech innovators.
デジタルヘルスの統合
Integrating digital health solutions with obesity therapeutics to enhance patient engagement, treatment adherence, and real-world outcomes through connected technologies and data-driven personalization.
専用ネットワーキングアワー
Connect with pharmaceutical executives, biotech innovators, clinical researchers, and investors during structured networking breaks designed to foster collaboration, exchange insights, and build strategic partnerships across the obesity innovation ecosystem.